Cipher Pharma announces Moberg Pharma’s nail fungus treating product MOB-015 fails to meet primary endpoint in phase 3 study: Mississauga Thursday, December 12, 2024, 18:00 Hrs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback